High glucose levels (hyperglycemia) and increased glucose metabolites have been shown to activate hepatic expression of ChREBP, resulting in the upregulation of hepatic lipogenic enzymes and favoring increased hepatic lipogenesis [56,57,58]. Here, MLXIPL is linked to Hyperglycemia.